Prostatis Group’s First Trust Materials AlphaDEX Fund FXZ Stock Holding History

Prostatis Group’s Portfolio FXZ Stock Details FXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,506	Closed	-$656K	–	143
2023 Q4	$656K	Buy	+9,506	New	+$601K	0.27%	75

Other funds holding FXZ

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

CPG

Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return

Prostatis Group's FXZ Position: Q1 2024 in Review

Prostatis Group sold out of First Trust Materials AlphaDEX Fund (FXZ) in Q1 2024, closing a stake of 9,506 shares — an estimated $656K sold.

Prostatis Group first reported a position in FXZ in Q4 2023 and held it in 1 quarter. The position peaked at $656K in Q4 2023. 130 funds tracked by Wall St. Rank hold FXZ as of Q1 2024.

Prostatis Group reported no remaining First Trust Materials AlphaDEX Fund position as of Q1 2024 after selling out during the quarter.
Prostatis Group sold 9,506 First Trust Materials AlphaDEX Fund shares in Q1 2024, an estimated $656K.
Prostatis Group first reported a position in First Trust Materials AlphaDEX Fund in Q4 2023 and held it in 1 quarter.
Prostatis Group's First Trust Materials AlphaDEX Fund position peaked at $656K in Q4 2023.
130 funds tracked by Wall St. Rank held First Trust Materials AlphaDEX Fund as of Q1 2024.

Based on Prostatis Group's 13F filing for Q1 2024, filed 21 Mar 2025.